Κεντρική σελίδα Επίκαιρα θέματα

anakoinoseis_timon_odontiat

koinoniki_eythini
nea_proonta

epikaira_themata



Δικαίωμα συνταγογράφησης και από ιδιώτες γιατρούς

Φάρμακα στους 9 εκατ. ασφαλισμένους στον νέο φορέα υπηρεσιών υγείας (ΕΟΠΠΥ) θα μπορούν να γράφουν από τα μέσα του 2012 όλοι ανεξαιρέτως οι γιατροί.

Συνταγές φαρμάκων από όλους τους ιδιώτες γιατρούς θα μπορούν να λαμβάνουν από το νέο έτος οι περίπου 9 εκατ. ασφαλισμένοι του νέου φορέα παροχών υγείας το ΕΟΠΥΥ, σύμφωνα με δημοσίευμα της Κυριακάτικης Ελευθεροτυπίας.
Περισσότερα...
 
No. 1 pharmacy drug to go generic [Tulsa World, Okla.]

Nov. 18 The best-selling pharmacy drug in history will have a generic competitor at the end of the month, meaning lower prices for consumers.

Lipitor, a drug that lowers cholesterol, made $11 billion for Pfizer, the company that created it, last year. It loses patent protection Nov. 30, and a generic drug by Watson Pharmaceuticals, Atorvastatin, will become available at that time.

After another six months, any company will be able to make Atorvastatin, and the price will drop even further.

Περισσότερα...
 
Lawmakers Target Drug Prices With Ramped-up Competition

Washington Roundup

WASHINGTON With drug prices continuing their upward climb, several senators are launching bipartisan efforts to shoot them down with increased competition. And that's putting pay-for-delay settlements at the center of congressional crosshairs.

The most recent effort, introduced Wednesday, "fixes an unintended problem in the Hatch-Waxman Act," according to a press release from Sen. Jeff Bingaman's (D-N.M.) office. The problem was created by the first filer provision that awards 180 days' exclusivity to the first generic drugmaker to file an abbreviated new drug application (ANDA) for a specific drug.

Περισσότερα...
 
 © Adipharm Limited. Created by Web intelligence.